The National Diagnostic Imaging Board has issued a briefing on the latest shortfall in the isotope Molybdenum, following the closure of one of the world’s largest reactors.
The paper demonstrates a strong collaboration between the Department of Health, the British Nuclear Medicine Society (BNMS) and commercial suppliers to ensure the effective communications for service providers and to enable the best use of restricted supplies for patient investigations.
Download the briefing paper.
